Get access

Recombinant growth hormone in Prader-Willi Syndrome

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the benefits and harms of hGH treatment in children aged 0-18 years with PWS. Specific benefits examined will be effects on growth, body mass index and energy expenditure.